DelistingPharmaSGP Holding SE: Delisting of PharmaSGP shares from Frankfurt Stock Exchange effective upon the expiry of August 11, 202506-Aug-2025 / 16:16 CET/CESTDisclosure of an inside information ...

Author:Shweta Raskar, Business Development Specialist, Prophecy Market InsightsIntroductionThe Europe Legal Cannabis Market ...

Global Proteomics Market is estimated to be valued at USD 123.1 Billion by 2035, with an exponential growth of 12.55% in the ...

Robert F. Kennedy Jr. has terminated nearly $500 million in U.S. federal mRNA vaccine contracts across 22 projects for ...

The global cell isolation market is projected to grow at a CAGR of 11% from 2025 to 2030, driven by rising investments in ...

The point of care molecular diagnostics market is experiencing steady growth, with a CAGR of ~6% driven by increasing demand ...

The global healthcare digital twin market is estimated to be approximately US$ 2.1 billion in 2024 and is set to witness a ...

Overview of 3D Bioprinting MarketThe global 3D Bioprinting Market is valued at USD 3 Billion in 2024 and is projected to ...

Overview of Surgical Equipment MarketThe Global Surgical Equipment Market is witnessing significant expansion, driven by the ...

The Gene Synthesis Market is valued at USD 2.81 Billion in 2024 and is expected to reach USD 13.64 Billion by 2035 at a CAGR ...

Clinical data and cost-effectiveness analysis demonstrates the VenoValve would provide both better health outcomes and lower costs compared to current standard of care treatmentsThe VenoValve could ...

MAX BioPharma and Revilico Collaboration LOS ANGELES, CA / ACCESS Newswire / August 6, 2025 / Today MAX BioPharma, Inc. ( and Revilico, Inc. ( announced their collaboration in studying the mechanisms ...